CT:WLLW Willow Biosciences, Inc.

Willow Biosciences, Inc. is a biotechnology company. It develops synthetic biology solutions for opioid biosynthesis. The firm offers biosynthetic production systems for plant-derived active pharmaceutical ingredients (API) and intermediates. The company was founded on April 12, 2019 and is headquartered in Calgary, Canada.

This company cross-lists their shares on a U.S. stock exchange. See the related U.S. symbol CANSF.

This company has cross-listed shares that trade in the U.S. as the symbol CANSF.

0.12 CAD
As of 09/29/2022

Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Developed markets ex-US
GICS sector:  Materials
Industry:  Drug Manufacturers-Specialty &
Index country:  Canada
Country of incorporation:  Canada
IPO date:  01/01/1900
Stock exchange:    Toronto Stock Exchange
Exchange country:   Canada
Market cap:   21,620,374 CAD
Current dividend yield:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy